Loading...

AVBP ARRIVENT BIOPHARMA INC Earnings Reports 8-K Filing

RRVN

VBP

ARRIVENT BIOPHARMA INC

(AVBP)

2026 8-K

Stock Offering Update

Financial Results Released

Presentation Announcement

Financial Results Report

Financial Results Announcement

Data Presentation

Product Expansion

Equity Offerings

Product Expansion

Financial Statements

Accounting Firm Change

Financial Results

License Agreement

Q3 Financial Results

Positive Trial Results

External Links:

On March 5, 2026, ArriVent BioPharma, Inc. announced its financial results for the fourth quarter and full year ending December 31, 2025. This filing is significant as it provides insights into the company's financial performance.

AI Assistant

ARRIVENT BIOPHARMA INC

2026

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.